Skip to main content
ICCM logo

ICCM · IceCure Medical Ltd.

Track ICCM — free
$3.02 +0.02 (+0.67%) At close · Aug 14
Market Cap
$10.35M
Shares
3.43M

IceCure Medical Ltd. Earnings Call Transcripts

Every quarterly earnings call for IceCure Medical Ltd. (ICCM) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-12
Q2 2026 Results Conference Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Annual General Meeting
Investor event
2026-08-06
Special General Meeting of Shareholders
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-12
Q1 2026 Results Conference Call
Confident tone U.S. commercial momentum post-FDA International expansion and other organs Revenue growth and Q1 results
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-17
IceCure Medical Ltd. Q1 FY2026 Earnings Call
Confident tone FDA marketing authorization for ProSense Reimbursement and CPT codes ASBRS guideline recommending cryoablation
Results not yet reported
Audio Transcript Slides 8-K10-K
Annual General Meeting
Investor event
2026-01-07
Special General Meeting of Shareholders
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2025-12-31
IceCure Medical Ltd. Q4 FY2025 Earnings Call
Confident tone FDA marketing authorization for ProSense Reimbursement and CPT codes ASBRS guideline recommending cryoablation
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
IceCure Medical Ltd. Q3 FY2025 Earnings Call
Confident tone FDA marketing authorization for ProSense International expansion and partnerships Revenue and financial performance
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
IceCure Medical Ltd. Q2 FY2025 Earnings Call
Confident tone FDA Regulatory Progress for ProSense European Adoption and International Conferences Japan Partnership with Terumo
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
IceCure Medical Ltd. Q1 FY2025 Earnings Call
Confident tone FDA marketing authorization and post-market study North America and Europe sales growth Early-stage breast cancer indication
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
IceCure Medical Ltd. Q2 FY2024 Earnings Call
Confident tone FDA advisory panel for breast cancer ProSense demand and sales growth Japan / Terumo partnership
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
IceCure Medical Ltd. Q1 FY2024 Earnings Call
Confident tone ICE3 study and FDA submission for breast cancer Next-generation XSense system Global commercial expansion and indications
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
IceCure Medical Ltd. Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
IceCure Medical Ltd. Q3 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
IceCure Medical Ltd. Q2 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
IceCure Medical Ltd. Q1 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
IceCure Medical Ltd. Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
IceCure Medical Ltd. Q3 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
IceCure Medical Ltd. Q2 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
IceCure Medical Ltd. Q1 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–19 of 19 earnings calls
Key facts CIK 1584371 CUSIP M53071201 13F (30d) 12 filings 12 filers Visit website Investor relations